Wan-Soo Yoon

Prof. Wan-Soo Yoon


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2023 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
WYWan-Soo Yoon
Wan-Soo Yoon
DCDong-Sup Chung
Dong-Sup Chung
Although immunotherapy has been broadly successful in the treatment of hematologic malignancies and a subset of solid tumors, its clinical outcomes for glioblastoma are still inadequate. The results could be due to neuroanatomical structures such as the bloodbrain- barrier, antigenic heterogeneity, and the highly immunosuppressive microenvironment of glioblastomas. The antitumor efficacy of endogenously activated effector cells induced by peptide or dendritic cell vaccines in particular has been insufficient to control tumors. Effector cells, such as T cells and natural killer (NK) cells can be expanded rapidly ex vivo and transferred to patients. The identification of neoantigens derived from tumor-specific mutations is expanding the list of tumor-specific antigens for glioblastoma. Moreover, recent advances in gene-editing technologies enable the effector cells to not only have multiple biological functionalities, such as cytokine production, multiple antigen recognition, and increased cell trafficking, but also relieve the immunosuppressive nature of the glioblastoma microenvironment by blocking immune inhibitory molecules, which together improve their cytotoxicity, persistence, and safety. Allogeneic chimeric antigen receptor (CAR) T cells edited to reduce graft-versushost disease and allorejection, or induced pluripotent stem cell-derived NK cells expressing CARs that use NK-specific signaling domain can be a good candidate for off-the-shelf products of glioblastoma immunotherapy. We here discuss current progress and future directions for T cell and NK cell therapy in glioblastoma.

24 October 2020 in Cancer Genomics & Proteomics
Verified
Journal Article
Open access
PDF file
NYNara Yoon
Nara Yoon
HKHyun-Soo Kim
Hyun-Soo Kim
JLJung Whee Lee
Jung Whee Lee
ELEui-Jin Lee
Eui-Jin Lee
LMLee-So Maeng
Lee-So Maeng
WYWan-Soo Yoon
Wan-Soo Yoon
Background/Aim: Glioblastoma is the most malignant form of astrocytoma. The purpose of this study was to analyze the genetic characteristics of primary and recurrent glioblastomas using targeted sequencing and investigate the differences in mutational profiles between the locations of tumor recurrence. Materials and Methods: Fourteen glioblastoma patients who developed local (n=10) or distal (n=4) recurrence were included in the study. Targeted sequencing analysis was performed using the primary (n=14) and corresponding recurrent (n=14) tumor tissue samples. Results: The local and distal recurrence groups showed different genetic evolutionary patterns. Most of the locally recurrent glioblastomas demonstrated concordant mutational profiles between the primary and recurrent tumors, suggesting a linear evolution. In contrast, all cases of distally recurrent glioblastomas showed changes in mutational profiles with newly acquired mutations when compared to the corresponding primary tumors, suggesting a branching evolution. Conclusion: Locally and distally recurrent glioblastomas exhibit different evolutionary patterns.

1 March 2021 in Journal of Korean Neurosurgical Society
Verified
Journal Article
Open access
PDF file
WYWan-Soo Yoon
Wan-Soo Yoon
HLHyoung-Woo Lho
Hyoung-Woo Lho
DCDong-Sup Chung
Dong-Sup Chung
Though the operating microscope (OM) has been the standard optical system in neurosurgery, a new technology called three-dimensional (3D) exoscope has emerged as an alternative. Herein, two types of 3D exoscopes for brain tumor surgery are presented. In addition, the advantages and limitations compared with the OM are discussed. In the present study, 3D exoscope VOMS-100 or VITOM 3D was used in 11 patients with brain tumor who underwent surgical resection; the Kinevo 900 OM was used only in emergency. After completion of all surgeries, the participants were surveyed with a questionnaire regarding video image quality on the display monitor, handling of equipment, ergonomics, educational usefulness, 3D glasses, and expectation as a substitute for the OM. Among 11 patients, nine patients underwent neurosurgical resection with only 3D exoscope; however, two patients required additional aid with the OM due to difficulty in hemostasis. Regarding video image quality, VITOM 3D was mostly equivalent to the OM, but VOMS-100 was not. However, both 3D exoscopes showed advantages in accessibility of instruments in the surgical field and occupied less space in the operating theater. Differences in ergonomics and educational usefulness between the exoscopes were not reported. Respondents did not experience discomfort in wearing 3D glasses and thought the exoscopes could be currently, and in the future, used as a substitute for the OM. Although many neurosurgeons are not familiar with 3D exoscopes, they have advantages compared with the OM and similar image quality. Exoscopes could be a substitute for OM in the future if some limitations are overcome.

25 September 2020 in Asia-Pacific Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
WYWan-Soo Yoon
Wan-Soo Yoon
JPJae‐Sung Park
Jae‐Sung Park
YKYoung‐Il Kim
Young‐Il Kim
DCDong‐Sup Chung
Dong‐Sup Chung
SJSin‐Soo Jeun
Sin‐Soo Jeun
SYSeung-Ho Yang
Seung-Ho Yang

1 January 2015 in Brain Tumor Research and Treatment
Verified
Journal Article
Open access
PDF file
JPJong-Heok Park
Jong-Heok Park
WYWan-Soo Yoon
Wan-Soo Yoon
DCDong-Sup Chung
Dong-Sup Chung
An intracranial cyst tumor with a mural nodule can be representative of some types of brain tumors, but is a rare presentation of intracranial inflammatory myofibroblastic tumor (IMT). Herein, we report the case of an intracranial IMT in a 48-year-old woman presenting with the extremely unusual radiologic findings of a cyst with a mural nodule.

26 October 2016 in British Journal Of Neurosurgery
Verified
Journal Article
Closed access
BCByung-Rae Cho
Byung-Rae Cho
WYWan-Soo Yoon
Wan-Soo Yoon
The most common intracranial tumour is meningioma, which rarely presents with extracranial metastasis, especially in benign cases. We report a case of meningioma recurrence with multiple pulmonary metastases in a patient who had a benign meningioma removed 12 years prior.